Maurizio Cibischino, MD
Orthopaedic Surgery · E Stroudsburg, PANPI 1124028832
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.9%), education and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Arthrex at 49.5% of the total. Reporting peaked in 2022 at $2,917 and has fallen 84.8% since, to $444 in 2025.
Across 83 payments — averaging $54.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Novus Surgical Solutions LLC$743
- Novus Surgical Consultants$383
- ERMI LLC$151
- Johnson & Johnson$150
- Pacira Therapeutics, Inc.$135
- plus $716 from 16 others
What the payments were for
- Travel & lodging$1,00422%
- Food & beverage$2,16048%
- Education$1,35030%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 17 | $2,236 |
| Novus Surgical Solutions LLC | 7 | $743 |
| Novus Surgical Consultants | 6 | $383 |
| ERMI LLC | 5 | $151 |
| Johnson & Johnson | 8 | $150 |
| Pacira Therapeutics, Inc. | 5 | $135 |
| Stryker | 2 | $97 |
| Endo Pharmaceuticals Inc. | 4 | $74 |
| Ferring Pharmaceuticals Inc. | 5 | $73 |
| Kowa Pharmaceuticals America, Inc. | 5 | $69 |
| Vertex | 2 | $61 |
| Bioventus LLC | 3 | $52 |
| Ossur Americas, Inc. | 1 | $49 |
| Zimmer Biomet | 1 | $45 |
| Collegium Pharmaceutical, Inc. | 3 | $42 |
| Smith+Nephew | 1 | $35 |
| Tersera Therapeutics LLC | 2 | $31 |
| Amgen | 2 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Organogenesis Inc. | 1 | $18 |
| Nevro Corp. | 1 | $15 |
| Biodelivery Sciences International, Inc. | 1 | $15 |
How this compares
$4,514 in reported general payments places this provider in the 55th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 60 | $4,606 |
| Celecoxib | 204 | $4,060 |
| Meloxicam | 251 | $780 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in E Stroudsburg
- William HozackBensalem$10.6M
- Jess LonnerBryn Mawr$7.8M
- Gerald WilliamsBryn Mawr$6.8M
- Mark LazarusBensalem$6.4M
- John FenlinPhiladelphia$5.9M
- Peter SharkeyKing Of Prussia$5.7M
- Alexander VaccaroPhiladelphia$4.5M
- Selene ParekhBensalem$4.5M
- Joseph AbboudPhiladelphia$3.9M
- Jonathan GarinoMalvern$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.